Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $3.24M invested in Celyad Oncology SA American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
64% less capital invested
Capital invested by funds: $9.07M → $3.24M (-$5.83M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$16.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$13.3K |
| 3 |
Millennium Management
New York
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$12.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.96K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2K |
| 5 |
Morgan Stanley
New York
|
-$608 |
CYAD Hedge Fund Activity: Q4 2022 in Review
8 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q4 2022, worth a combined $3.24M — down 64% from $9.07M a quarter earlier.
Fund positioning in CYAD was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $16.5K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $16K sold.
- 8 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $3.24M of Celyad Oncology SA American Depositary Shares stock for Q4 2022, down 64% quarter-over-quarter.
- 2 funds opened new Celyad Oncology SA American Depositary Shares positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q4 2022 was Old Mission Capital, an estimated $16.5K added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q4 2022 was Susquehanna International Group, an estimated $16K sold.
Based on aggregated 13F filings for Q4 2022.